| scholarly article | Q13442814 |
| P2093 | author name string | William C Wimley | |
| Charles G Starr | |||
| P2860 | cites work | MSI-78, an Analogue of the Magainin Antimicrobial Peptides, Disrupts Lipid Bilayer Structure via Positive Curvature Strain | Q24537642 |
| Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor | Q24569680 | ||
| Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis | Q24645094 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America | Q28183380 | ||
| Defensins: antimicrobial peptides of innate immunity | Q28204453 | ||
| Invasion of red blood cells by malaria parasites | Q29618806 | ||
| Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry | Q33350452 | ||
| Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides | Q33788748 | ||
| Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications | Q33938255 | ||
| Peptide transporters in the intestine and the kidney | Q34063366 | ||
| Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity | Q34112173 | ||
| Mechanisms of antimicrobial peptide action and resistance | Q34181099 | ||
| Describing the mechanism of antimicrobial peptide action with the interfacial activity model | Q34204118 | ||
| Host Cell Interactions Are a Significant Barrier to the Clinical Utility of Peptide Antibiotics | Q34543763 | ||
| Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes | Q34579250 | ||
| A systematic review of adherence with medications for diabetes | Q35757475 | ||
| APD3: the antimicrobial peptide database as a tool for research and education | Q36434966 | ||
| Strategies to improve plasma half life time of peptide and protein drugs | Q36452632 | ||
| Mechanism Matters: A Taxonomy of Cell Penetrating Peptides. | Q36503914 | ||
| Antibacterial peptides for therapeutic use: obstacles and realistic outlook | Q36556909 | ||
| Is the oral route possible for peptide and protein drug delivery? | Q36601912 | ||
| Erythrocyte membrane vesiculation: model for the molecular mechanism of protein sorting | Q36714217 | ||
| Synthetic therapeutic peptides: science and market | Q37625355 | ||
| Molecular mechanisms of antibiotic resistance. | Q38272908 | ||
| Peptide therapeutics: current status and future directions | Q38275750 | ||
| Recent in vivo advances in cell-penetrating peptide-assisted drug delivery. | Q38658534 | ||
| Proteolytic degradation of human erythrocyte band 3 by membrane-associated protease activity | Q39567980 | ||
| Ebola Virus Delta Peptide is a Viroporin | Q40055714 | ||
| Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs | Q41979383 | ||
| Sequence and specificity of two antibacterial proteins involved in insect immunity | Q42077306 | ||
| Spontaneous membrane-translocating peptides by orthogonal high-throughput screening | Q42254224 | ||
| In-depth analysis of the membrane and cytosolic proteome of red blood cells | Q42692507 | ||
| Antimicrobial peptides stage a comeback | Q44370091 | ||
| Cell-Density Dependence of Host-Defense Peptide Activity and Selectivity in the Presence of Host Cells | Q44511359 | ||
| Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils | Q44563317 | ||
| Macroxyproteinase (M.O.P.): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. | Q45054752 | ||
| Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. | Q46762144 | ||
| Spontaneous Membrane Translocating Peptides: The Role of Leucine-Arginine Consensus Motifs | Q47762139 | ||
| Functional 20S proteasomes in mature human red blood cells. | Q50539522 | ||
| How many antimicrobial peptide molecules kill a bacterium? The case of PMAP-23. | Q53268697 | ||
| Intravascular hemolysis as a complication of clostridium perfringens sepsis. | Q53622118 | ||
| Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. | Q54099814 | ||
| The ATP-independent pathway in red blood cells that degrades oxidant-damaged hemoglobin | Q67926150 | ||
| Proteins damaged by oxygen radicals are rapidly degraded in extracts of red blood cells | Q69060872 | ||
| Red blood cells contain a pathway for the degradation of oxidant-damaged hemoglobin that does not require ATP or ubiquitin | Q70137832 | ||
| Purification and characterization of acid proteinase from human erythrocyte membranes | Q70387229 | ||
| Hemolytic anemia | Q80212472 | ||
| Improved proteolytic stability of chicken cathelicidin-2 derived peptides by D-amino acid substitutions and cyclization | Q83534410 | ||
| P433 | issue | 12 | |
| P921 | main subject | antimicrobial peptide | Q1201508 |
| human erythrocyte | Q111535219 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 2319-2326 | |
| P577 | publication date | 2017-09-11 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Antimicrobial peptides are degraded by the cytosolic proteases of human erythrocytes | |
| P478 | volume | 1859 |
| Q98178327 | Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy |
| Q90584464 | Antimicrobial peptides: new hope in the war against multidrug resistance |
| Q93067924 | Application of Synthetic Molecular Evolution to the Discovery of Antimicrobial Peptides |
| Q98237705 | Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides |
| Q91651339 | Potential factors contributing to the poor antimicrobial efficacy of SAAP-148 in a rat wound infection model |
| Q96303599 | Strategies in Translating the Therapeutic Potentials of Host Defense Peptides |
| Q98465528 | The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design |
Search more.